SCHEMBL5776409

SCHEMBL5776409

CCOP(=O)(Cc1ccc(NC(=O)Cc2cnoc2-c2ccccc2)cc1)OCC

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.42
KMT2A Q03164 4/20 0.42
HPGD P15428 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HSD17B10 Q99714 2/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
CACNA1B Q00975 1/20 0.42
APBA1 Q02410 1/20 0.42
NPY5R Q15761 1/20 0.41
MAPT P10636 3/20 0.41
POLB P06746 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
LMNA P02545 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PKM P14618 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5771726 0.90 LTA4H (0.46) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL5775547 0.90 KMT2A (0.46) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL5773366 0.89 LTA4H (0.43) MEN1KMT2AHPGDALDH1A1NPY5R
SCHEMBL5772488 0.86 LTA4H (0.49) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL5777451 0.83 MEN1 (0.41) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL5772612 0.83 LTA4H (0.46) MEN1KMT2AHPGDALDH1A1KDM4E
SCHEMBL5775872 0.82 BTK (0.41) MEN1KMT2AKDM4ENPY5RMAPT
SCHEMBL5771359 0.81 MEN1 (0.40) MEN1KMT2AALDH1A1NPY5RMAPT
SCHEMBL5777014 0.81 MEN1 (0.46) MEN1KMT2AKDM4EMAPTNPSR1
SCHEMBL5770775 0.80 MAPT (0.41) MEN1KMT2AHPGDALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR MEN1 2811/4885KMT2A 3907/4885HPGD 1588/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 MEN1 2072/4885KMT2A 2906/4885HPGD 1307/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.